Kristian Bjøro

Bilde av Kristian Bjøro
English version of this page
Mobiltelefon 90186524 901 86524
Treffetider Kontor tlf 23070715
Brukernavn
Besøksadresse Kirkeveien 166 Søsterhjemmet 0450 OSLO
Postadresse Postboks 1171 Blindern 0318 OSLO

Publikasjoner

  • Dalgard, Olav; Martinot-Peignoux, Michelle; Verbaan, Hans; Bjøro, Kristian; Ring-Larsen, Helmer & Marcellin, Patrick (2015). The usefulness of defining rapid virological response by a very sensitive assay (TMA) during treatment of HCV genotype 2/3 infection. PLoS ONE.  ISSN 1932-6203.  10(8) . doi: 10.1371/journal.pone.0120866
  • Fosby, Bjarte; Melum, Espen; Bjøro, Kristian; Bennet, William; Rasmussen, Allan; Andersen, Ina Riise; Castedal, Maria; Olausson, Michael; Wibeck, Christina; Gotlieb, Mette; Gjertsen, Henrik; Toivonen, Leena; Foss, Stein; Mäkisalo, Heikki; Nordin, Arno; Sanengen, Truls; Bergquist, Annika; Larsson, Marie E.; Söderdahl, Gunnar; Nowak, Greg; Boberg, Kirsten Muri; Isoniemi, Helena; Keiding, Susanne; Foss, Aksel; Line, Pål Dag; Friman, Styrbjörn; Schrumpf, Erik; Ericzon, Bo-Göran; Höckerstedt, Krister & Karlsen, Tom Hemming (2015). Liver transplantation in the Nordic countries-An intention to treat and post-transplant analysis from the Nordic Liver Transplant Registry 1982-2013. Scandinavian Journal of Gastroenterology.  ISSN 0036-5521.  50(6), s 797- 808 . doi: 10.3109/00365521.2015.1036359
  • Eskesen, Arne N; Bjøro, Kristian; Aandahl, Einar Martin; Line, Pål Dag & Melum, Espen (2014). Low use of surveillance and early diagnosis of hepatocellular carcinoma in Norway-A population-based cohort study. Cancer Epidemiology.  ISSN 1877-7821.  38(6), s 741- 747 . doi: 10.1016/j.canep.2014.10.005
  • Eskesen, Arne N; Melum, Espen; Moghaddam, Amir; Bjøro, Kristian; Verbaan, Hans; Ring-Larsen, Helmer & Dalgard, Olav (2012). Genetic variants at the ITPA locus protect against ribavirin-induced hemolytic anemia and dose reduction in an HCV G2/G3 cohort. European Journal of Gastroenterology and Hepathology.  ISSN 0954-691X.  24(8), s 890- 896 . doi: 10.1097/MEG.0b013e3283546efd
  • Moghaddam, Amir; Melum, Espen; Reinton, Nils; Ring-Larsen, Helmer; Verbaan, Hans; Bjøro, Kristian & Dalgard, Olav (2011). IL28B Genetic Variation and Treatment Response in Patients with Hepatitis C Virus Genotype 3 Infection. Hepatology.  ISSN 0270-9139.  53(3), s 746- 754 . doi: 10.1002/hep.24154
  • Dahl, Tuva Børresdatter; Haukeland, John Willy; Yndestad, Arne; Ranheim, Trine; Gladhaug, Ivar Prydz; Damås, Jan Kristian; Haaland, Therese Kristina; Løberg, Else Marit; Arntsen, Borghild M; Birkeland, Kåre I.; Bjøro, Kristian; Ulven, Stine Marie; Zbigniew, Konopski; Nebb, Hilde Irene; Aukrust, Pål & Halvorsen, Bente (2010). Intracellular Nicotinamide Phosphoribosyltransferase Protects against Hepatocyte Apoptosis and Is Down-Regulated in Nonalcoholic Fatty Liver Disease. Journal of Clinical Endocrinology and Metabolism.  ISSN 0021-972X.  95(6), s 3039- 3047 . doi: 10.1210/jc.2009-2148
  • Dalgard, Olav; Bjøro, Kristian; Ring-Larsen, H. & Verbaan, H (2010). In patients with HCV genotype 2 or 3 infection and RVR 14 weeks treatment is noninferior to 24 weeks. Pooled analysis of two Scandinavian trials. European Journal of Gastroenterology and Hepathology.  ISSN 0954-691X.  22(5), s 552- 556 . doi: 10.1097/MEG.0b013e328335b29e
  • Haukeland, John Willy; Zbigniew, Konopski; Eggesbø, Heidi Beate; von Volkmann, HL; Raschpichler, G; Bjøro, Kristian; Haaland, Therese Kristina; Loberg, EM & Birkeland, Kåre I. (2009). Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial. Scandinavian Journal of Gastroenterology.  ISSN 0036-5521.  44(7), s 853- 860 . doi: 10.1080/00365520902845268
  • Haukeland, John Willy; Damås, Jan Kristian; Konopski, Zbigniew; Loberg, EM; Haaland, T; Goverud, I; Torjesen, PA; Birkeland, Kåre I.; Bjøro, Kristian & Aukrust, Pål (2006). Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. Journal of Hepatology.  ISSN 0168-8278.  44(6), s 1167- 1174
  • Brandsæter, Bjørn Jardar; Schrumpf, Erik; Bentdal, Øystein H.; Braband, Knut; Smith, Hans-Jørgen; Abildgaard, Andreas; Bjøro, Kristian & Clausen, Ole Petter Fraas (2005). Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors. Liver transplantation.  ISSN 1527-6465.  11(11), s 1361- 1369
  • Haukeland, John Willy; Zbigniew, Konopski; Linnestad, P.; Azimy, S.; Løberg, Else Marit; Haaland, T.; Birkeland, Kåre I. & Bjøro, Kristian (2005). Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease. Scandinavian Journal of Gastroenterology.  ISSN 0036-5521.  40(12), s 1469- 77
  • Bjøro, Kristian; Schou, IH; Smeby, Nina Aarhus & Hamilton, G (2004). A strategy for establishing hospital based Nursing Research in Norway. Vård i Norden.  ISSN 0107-4083.  24(1), s 42- 44
  • Brandsæter, Bjørn Jardar; Isoniemi, H; Broome, U; Olausson, M; Backman, L; Hansen, B; Schrumpf, Erik; Oksanen, A; Ericzon, BG; Hockerstedt, K; Makisalo, H; Kirkegaard, P; Friman, S & Bjøro, Kristian (2004). "Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy". Journal of Hepatology.  ISSN 0168-8278.  40, s 815- 822
  • Brandsæter, Bjørn Jardar; Schrumpf, Erik; Clausen, Ole Petter Fraas; Abildgaard, Andreas; Hafsahl, Geir & Bjøro, Kristian (2004). Recurrent sclerosing cholangitis or ischemic bile duct lesions - a diagnostic challenge?. Liver transplantation.  ISSN 1527-6465.  10(8), s 1073- 1074
  • Dalgaard, O; Bjøro, Kristian; Block Hellum, K; Myrvang, B; Ritland, S; Skaug, K; Raknerud, N & Bell, H (2004). Treatment with pegylated interferon and ribavarin in HCV infection with genotype 2 og 3 for 14 weeks: a pilot study. Hepatology.  ISSN 0270-9139.  40, s 1260- 1265
  • Rokkones, Erik; Fromm, Sigurd H.; Kareem, Najma B.; Klungland, Helge; Olstad, Ole K.; Høgset, Anders; Iversen, Jan; Bjøro, Kristian & Gautvik, Kaare M. (1995). Human Parathyroid Hormone as a Secretory Peptide in Milk of Transgenic Mice. Journal of Cellular Biochemistry.  ISSN 0730-2312.  59, s 168- 176

Se alle arbeider i Cristin

  • Jørgensen, Silje; Macpherson, Magnhild E; Bjøro, Kristian; Karlsen, Tom Hemming; Reims, Henrik Mikael; Grzyb, Krzysztof; Fosby, Bjarte; Fevang, Børre; Aukrust, Pål & Nordøy, Ingvild (2016). Liver transplantation in patients with primary antibody deficiency. Journal of Allergy and Clinical Immunology.  ISSN 0091-6749. . doi: 10.1016/j.jaci.2016.10.025
  • Bjøro, Kristian (2010). This month in Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology.  ISSN 0036-5521.  45(6), s 643- 644 . doi: 10.3109/00365521.2010.488881
  • Dalgard, Olav; Moghaddam, Amir; Verbaan, Hans; Ring-Larsen, Helmer; Bjøro, Kristian & Melum, Espen (2010). IL28B GENETIC VARIATION AND TREATMENT RESPONSE IN PATIENTS WITH HCV GENOTYPE 3 INFECTION. Hepatology.  ISSN 0270-9139.  52(4), s 751A- 751A
  • Carvalho, RJ; Verbaan, H; Bjøro, Kristian; Ring-Larsen, H & Dalgard, O (2009). LOW-TO-MODERATE ALCOHOL CONSUMPTION HAS NO IMPACT ON ANTIVIRAL RESPONSE TO COMBINATION THERAPY IN HCV PATIENTS WITH GENOTYPE 2 OR 3. Hepatology.  ISSN 0270-9139.  50(4), s 687A- 688A
  • Dalgard, Odd Steffen; Bjøro, Kristian; Ring-Larsen, H & Verbaan, H (2008). Is sustained virological response to HCV treatment associated with a clinical important improvement in vitality?. Journal of Hepatology.  ISSN 0168-8278.  48, s S272- S272
  • Dalgard, Olav; Verbaan, H; Ring-Larsen, H & Bjøro, Kristian (2008). IN PATIENTS WITH HCV GENOTYPE 2 OR 3 INFECTION AND RVR 14 WEEKS TREATMENT IS NON-INFERIOR TO 24 WEEKS. POOLED ANALYSIS OF TWO SCANDINAVIAN TRIALS. Hepatology.  ISSN 0270-9139.  48(4), s 1148A- 1148A
  • Haukeland, John Willy; Zbigniew, Konopski; Loberg, EM; Haaland, Therese Kristina; von Volkmann, HL; Raschpichler, G; Eggesbo, HB; Bjøro, Kristian & Birkeland, K (2008). A RANDOMIZED, PLACEBO CONTROLLED TRIAL WITH METFORMIN IN PATIENTS WITH NAFLD. Hepatology.  ISSN 0270-9139.  48(4), s 334A- 334A
  • Schrumpf, Erik & Bjøro, Kristian (2008). Timing of liver transplantation in PSC. Scandinavian Journal of Gastroenterology.  ISSN 0036-5521.  43, s 31- 31
  • Dalgard, O; Bjøro, Kristian; Hellum, K; Myrvang, B; Ritland, S; Skaug, K; Raknerud, N & Bell, H (2004). Short (14 weeks) treatment with pegylated interferon alpha-2B and ribavirin in patients with hepatitis C genotype 2/3 virus infection and early virological response. Hepatology.  ISSN 0270-9139.  40, s 252A- 252A

Se alle arbeider i Cristin

Publisert 13. apr. 2011 11:36 - Sist endret 27. mai 2014 12:28

Forskergrupper